StreetInsider.com News Articles

Form 8-K Definitive Healthcare For: Aug 28

Fri, 11 Sep 2026 10:11:00 -0400

si-local-file:///var/storage/secattach/20260911/27051464.html

BTIG Reiterates Neutral Rating on Definitive Healthcare Corp (DH)

Fri, 04 Sep 2026 05:48:31 -0400

BTIG analyst David Larsen reiterated a Neutral rating on Definitive Healthcare Corp (NASDAQ: DH).

The analyst comments "On Wednesday morning 9/2/26, DH announced that it received a non-binding indication of interest, dated 9/1/26, from private equity firm Advent International (Private) to acquire all outstanding shares of Class A common stock, that are not already owned by Advent or Founder and Executive Chairman Jason Krantz, in an all-cash deal for ~$1.02 per share, which is a ~13% premium from the $0.90 closing share price on Tuesday. Based on the Schedule 13D filed by Advent, it has a beneficial ownership of ~58.54% of

Advent International proposes $1.02-per-share buyout of Definitive Healthcare

Wed, 02 Sep 2026 09:16:52 -0400

Advent International, L.P. has submitted a non-binding proposal to take Definitive Healthcare Corp. (Nasdaq: DH) private, offering $1.02 per share in cash for all outstanding Class A common stock not already held by Advent or company founder and Executive Chairman Jason Krantz, according to a statement from the company's special committee.

The proposal, dated September 1, 2026, also covers outstanding limited liability company interests of AIDH TopCo, LLC, at an equivalent per-unit price. Advent is making the offer on behalf of certain of its managed funds.

Definitive Healthcare's board formed a special committee, composed entirely of independent and disinterested directors, to evaluate

Advent International proposes $1.02-per-share buyout of Definitive Healthcare

Wed, 02 Sep 2026 09:16:52 -0400

Definitive Healthcare's board formed a special committee, composed entirely of independent and disinterested directors, to evaluate

Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International

Wed, 02 Sep 2026 09:15:00 -0400

FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- The special committee (the “Special Committee”) of the Board of Directors of Definitive Healthcare Corp. (the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it has received a non-binding indication of interest (the “Proposal”), dated as of September 1, 2026, from Advent International, L.P., on behalf of certain of its managed funds (collectively, “Advent”), to acquire all of the outstanding shares of the Company’s Class A common stock (the “Class A Common Stock”) and all of the outstanding limited liability company interests

Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International

Wed, 02 Sep 2026 09:15:00 -0400

Advent International offers $1.02 per share to acquire Definitive Healthcare

Wed, 02 Sep 2026 08:37:31 -0400

Advent International, L.P. has submitted a non-binding proposal to acquire all outstanding shares of Definitive Healthcare Corp. (NASDAQ: DH) Class A common stock not already owned by Advent and Executive Chairman Jason Krantz, according to a letter dated September 1, 2026.

The offer price of $1.02 per share represents a 36% premium to the company's 60-day volume-weighted average daily trading price of $0.75 per share as of market close on August 31, 2026. The proposal also includes an equivalent per-unit price for outstanding limited liability company interests of AIDH TopCo, LLC.

The proposal is contingent on Krantz, the company's founder and Executive

Advent International offers $1.02 per share to acquire Definitive Healthcare

Wed, 02 Sep 2026 08:37:31 -0400

The proposal is contingent on Krantz, the company's founder and Executive

Advent International offers $1.02 per share to acquire Definitive Healthcare

Wed, 02 Sep 2026 08:37:31 -0400

The proposal is contingent on Krantz, the company's founder and Executive

Advent International offers $1.02 per share to acquire Definitive Healthcare

Wed, 02 Sep 2026 08:37:31 -0400

The proposal is contingent on Krantz, the company's founder and Executive

Definitive Healthcare names Clay Ritchey as new CEO

Wed, 02 Sep 2026 08:30:16 -0400

Definitive Healthcare Corp. (Nasdaq: DH) has appointed Clay Ritchey as Chief Executive Officer and as a member of its Board of Directors, effective September 8, 2026, according to a company statement.

Ritchey succeeds Kevin Coop, who departed as CEO and board member on August 31, 2026. Coop had held the position since June 2024.

Ritchey joins Definitive Healthcare from Verato, a healthcare master data management company, where he also served as CEO. Prior to Verato, he held senior roles at several healthcare-focused companies, including CEO of Evariant before its acquisition by Healthgrades, Chief Marketing Officer at Imprivata, and CEO of Equinox Healthcare.

Definitive Healthcare names Clay Ritchey as new CEO

Wed, 02 Sep 2026 08:30:16 -0400

Ritchey succeeds Kevin Coop, who departed as CEO and board member on August 31, 2026. Coop had held the position since June 2024.

Definitive Healthcare Appoints Clay Ritchey as CEO

Wed, 02 Sep 2026 08:30:00 -0400

Mr. Ritchey brings more than 25 years of deep healthcare expertise to Definitive

FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Board of Directors has appointed Clay Ritchey as the Company’s next Chief Executive Officer and as a member of the Board of Directors, each effective September 8, 2026. Mr. Ritchey succeeds Kevin Coop, who departed as CEO and as a member of the Board of Directors, effective August 31, 2026. Mr. Coop had served as CEO since June

Definitive Healthcare Appoints Clay Ritchey as CEO

Wed, 02 Sep 2026 08:30:00 -0400

Mr. Ritchey brings more than 25 years of deep healthcare expertise to Definitive

Definitive Healthcare Corp (DH) PT Lowered to $1.50 at Morgan Stanley

Tue, 11 Aug 2026 09:08:48 -0400

Morgan Stanley analyst Craig Hettenbach lowered the price target on Definitive Healthcare Corp (NASDAQ: DH) to $1.50 (from $2.50) while maintaining a Equalweight rating.

Definitive Healthcare Corp. (DH) Tops Q2 EPS by 1c

Mon, 10 Aug 2026 17:33:55 -0400

Definitive Healthcare Corp. (NASDAQ: DH) reported Q2 EPS of $0.05, $0.01 better than the analyst estimate of $0.04. Revenue for the quarter came in at $55.2 million versus the consensus estimate of $55.48 million.

For earnings history and earnings-related data on Definitive Healthcare Corp. (DH) click here.

Form 10-Q Definitive Healthcare For: Jun 30

Mon, 10 Aug 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260810/26898505.html

Form 10-Q Definitive Healthcare For: Jun 30

Mon, 10 Aug 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260810/26898505.html

Form 8-K Definitive Healthcare For: Aug 10

Mon, 10 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260810/26897960.html

Form 8-K Definitive Healthcare For: Aug 10

Mon, 10 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260810/26897960.html

Definitive Healthcare Reports Financial Results for Second Quarter 2026

Mon, 10 Aug 2026 16:05:00 -0400

Second Quarter Revenue Within Guidance Range; Profit Surpasses Expectations

FRAMINGHAM, Mass., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter ended June 30, 2026.

Second Quarter 2026 Financial Highlights:

Revenue was $55.2 million, a decrease of 9% from $60.8 million in Q2 2025.
Net Loss was $(7.5) million, or (14)% of revenue, compared to $(9.3) million, or (15)% of revenue in Q2 2025.
Adjusted Net Income

Definitive Healthcare Reports Financial Results for Second Quarter 2026

Mon, 10 Aug 2026 16:05:00 -0400

Second Quarter Revenue Within Guidance Range; Profit Surpasses Expectations
FRAMINGHAM, Mass., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter ended June 30, 2026.

Second Quarter 2026 Financial Highlights:

Revenue was $55.2 million, a decrease of 9% from $60.8 million in Q2 2025.
Net Loss was $(7.5) million, or (14)% of revenue, compared to $(9.3) million, or (15)% of revenue in Q2 2025.
Adjusted Net Income

Definitive Healthcare launches early adopter program for AI platform

Thu, 06 Aug 2026 09:05:40 -0400

Definitive Healthcare (Nasdaq: DH), a healthcare data and analytics company, announced an early adopter program for a new AI-powered platform, with general availability planned for late 2026.
The Framingham, Mass.-based company said select customers, including health systems, life sciences organizations, and companies selling into healthcare, are being invited to participate beginning in August 2026. Feedback from participants will inform the final product before its planned broader release.
According to a press release, the platform combines Definitive Healthcare's existing data assets — covering providers, organizations, claims, affiliations, key opinion leaders, and consumer datasets — with conversational AI. The company said the platform is

Definitive Healthcare Launches Early Adopter Program for New AI-Powered Healthcare Intelligence Platform

Thu, 06 Aug 2026 09:05:00 -0400

Unifying claims, provider, consumer, and expert data enables organizations to uncover growth opportunities and make faster, better-informed decisions
FRAMINGHAM, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), a provider of healthcare data and analytics, today announced an early adopter program for its new AI-powered platform, giving select organizations early access as the company works toward general availability later this year.

Definitive Healthcare is advancing its AI strategy by combining its trusted healthcare data assets with conversational AI to surface insights across providers, organizations, claims, affiliations, KOLs, and consumer datasets.

The platform will enable users

Definitive Healthcare Launches Early Adopter Program for New AI-Powered Healthcare Intelligence Platform

Thu, 06 Aug 2026 09:05:00 -0400

Unifying claims, provider, consumer, and expert data enables organizations to uncover growth opportunities and make faster, better-informed decisions
FRAMINGHAM, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), a provider of healthcare data and analytics, today announced an early adopter program for its new AI-powered platform, giving select organizations early access as the company works toward general availability later this year.

Definitive Healthcare is advancing its AI strategy by combining its trusted healthcare data assets with conversational AI to surface insights across providers, organizations, claims, affiliations, KOLs, and consumer datasets.

The platform will enable users